Download this White Paper
Digital health solutions have a great potential to improve the lives of people with chronic conditions. However, the use of these solutions in the commercial setting for pharma is still growing, creating a need for the pharma industry to assess the strategic challenges and consider the current plans it has in place.
As a result, pharma as an industry is now facing fundamental questions about how organizations are structured, and the methodologies in place for the development of digital health solutions, such as:
This whitepaper will tackle these questions, sharing the perspectives of industry leaders from Takeda, Pfizer, Novartis and S3 Connected Health, diving into what success looks like, how a shift in mindset can reset the path to successful development and market adoption of digital health solutions, and the importance of building the structures required to realize a long-term vision.
Offered Free by: S3 Connected Health
See All Resources from: S3 Connected Health